4-(butyldipentylstannyl)-1-methyl-1H-imidazole | 1422982-61-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-(butyldipentylstannyl)-1-methyl-1H-imidazole
• 英文别名: 3-methylimidazole；butyl-(1-methylimidazol-4-yl)-dipentylstannane
• CAS: 1422982-61-3
• 化学式: C₁₈H₃₆N₂Sn
• 分子量: 399.207
• InChiKey: ZQQGWTVWMKTSJB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.26
• 重原子数：
  21
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4-(butyldipentylstannyl)-1-methyl-1H-imidazole 、 5-溴-2-羟基-3-甲氧基苯甲醛 在 四(三苯基膦)钯 、 sodium carbonate 作用下， 以 甲苯 为溶剂， 生成
  参考文献：
  名称：

  Synthesis and two-photon absorption properties of unsymmetrical metallosalophen complexes

  摘要：

  Several new unsymmetrical metallosalphen complexes derived from the condensation of a monoimine and salicylaldehyde in the presence of a transition metal ion as a template have been synthesized and characterized. Their linear and third-order non-linear optical (NLO) properties have been investigated in detail. With different substituted donor or acceptor groups at the 5-position of the salicylidene fragment, these metallosalophen complexes exhibit slightly different two-photon absorption (TPA) cross-section sigma((2)) values. Theoretical calculations based on density functional theory were also carried out to help with the interpretations of the experimental results. (c) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.poly.2012.09.050

文献信息

• [EN] INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE<br/>[FR] COMPOSÉS D'INDAZOLE, COMPOSITIONS ET PROCÉDÉS D'UTILISATION
  申请人：HOFFMANN LA ROCHE

  公开号：WO2013024011A1

  公开（公告）日：2013-02-21

  A compound of formula I: stereoisomers or a pharmaceutically acceptable salt thereof, wherein X, X1, X2, X3, R1, R2, R3, R4, R5 and R6 are described herein, compositions including the compounds and methods of making and using the compounds for the treatment of diseases.

  公式I的化合物：其立体异构体或其药学上可接受的盐，其中X、X1、X2、X3、R1、R2、R3、R4、R5和R6如本文所述，包括该化合物的组合物以及用于治疗疾病的制备和使用该化合物的方法。
• INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
  申请人：Genentech, Inc.

  公开号：US20140309210A1

  公开（公告）日：2014-10-16

  A compound of formula I: stereoisomers or a pharmaceutically acceptable salt thereof, wherein X, X 1 , X 2 , X 3 , R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are described herein, compositions including the compounds and methods of making and using the compounds for the treatment of diseases.

  化合物I的公式：立体异构体或其药学上可接受的盐，其中X，X1，X2，X3，R1，R2，R3，R4，R5和R6如本文所述，包括该化合物的组合物以及使用该化合物治疗疾病的方法和制备方法。
• Synthesis and two-photon absorption properties of unsymmetrical metallosalophen complexes
  作者：Jie Zhang、Cheng Zhong、XunJin Zhu、Hoi-Lam Tam、King-Fai Li、Kok-Wai Cheah、Wai-Yeung Wong、Wai-Kwok Wong、Richard A. Jones

  DOI：10.1016/j.poly.2012.09.050

  日期：2013.1

  Several new unsymmetrical metallosalphen complexes derived from the condensation of a monoimine and salicylaldehyde in the presence of a transition metal ion as a template have been synthesized and characterized. Their linear and third-order non-linear optical (NLO) properties have been investigated in detail. With different substituted donor or acceptor groups at the 5-position of the salicylidene fragment, these metallosalophen complexes exhibit slightly different two-photon absorption (TPA) cross-section sigma((2)) values. Theoretical calculations based on density functional theory were also carried out to help with the interpretations of the experimental results. (c) 2012 Elsevier Ltd. All rights reserved.